Phase II trial code: 1066
This is an early-stage medical study, known as a Phase II trial (code: 1066). At the moment, we can't provide the full details about what this study is looking into or the treatments being tested. This is because the Health Research Authority (HRA), which oversees medical research in the UK, has given us permission to delay publishing this information. They do this sometimes to protect new ideas or pending discoveries. This doesn't affect the safety or ethical standards of the trial. All the complete information will be made public and added to the study's official record within 30 months after the trial officially concludes. Participants in this study will be between 40 and 85 years old, and it is open to both men and women.
At a glance
What is this study about?
This study is a Phase II clinical trial. Clinical trials are research studies that test new treatments or ways of using existing treatments in people. They are carefully designed to find out if a new treatment is safe and effective.
In the UK, all clinical trials must follow strict rules and are checked by special committees, including the Health Research Authority (HRA). The HRA makes sure that research is ethical and that people taking part are safe. For this specific trial, the HRA has allowed us to hold back some of the detailed information for a period. This is not unusual and is sometimes done to protect new research discoveries or commercial interests until they are ready to be fully shared.
While we can't share all the details right now, please be assured that the study is ongoing and is being conducted safely and ethically. We know it can be frustrating not to have all the information, but this deferral doesn't affect the quality or safety of the trial. All the complete details of the study, including what it's testing and the results, will be made publicly available within 30 months after the trial has finished.
Key takeaways
- This is an early-stage (Phase II) medical research study.
- Full details about the study are temporarily being kept private by approval from the UK's Health Research Authority (HRA).
- All study information will be made public within 30 months after the trial ends.
- People aged 40 to 85, both men and women, are eligible to join.
- Your health and safety are carefully monitored in all clinical trials.
Who may be eligible?
Unfortunately, at this moment, the specific details about who can and cannot join this study are not available. This is because the Health Research Authority (HRA) has given us special permission to keep this information private for a while.
What we do know is that this study is looking for volunteers who are between 40 and 85 years old. It is open to both men and women.
As soon as the full details are released (within 30 months after the trial ends), we will update this information. If you're interested in similar studies, you might want to speak to your doctor who can advise you based on your personal health.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 40 and 85 years old?
- Are you a man or a woman? (Both sexes are included)
- Are you generally interested in helping medical research?
- Are you willing to consider joining a study where full details are not yet public?
What does participation involve?
Because the full details of this study are currently not public, we cannot provide specific information about what taking part would involve. Generally, in a clinical trial, participation might include:
* **Regular visits:** You might need to attend a clinic or hospital for check-ups, tests, or to receive study medication. * **Assessments:** These could include blood tests, scans, physical examinations, or questionnaires about how you're feeling. * **Medication:** You might be given a new drug, an existing drug, or a placebo (a dummy treatment with no active drug). * **Follow-up:** Even after the main treatment period, you might have follow-up calls or visits to see how you are doing long-term.
The total time commitment varies greatly from study to study, but it is always made clear to participants before they agree to join. All these aspects would be fully explained in a document called an 'informed consent form' before you decide to take part.
Potential risks and benefits
Locations (1)
- -UnverifiedNO COUNTRY SPECIFIED, assuming England, England
Common questions
What is a Phase II trial?
A Phase II trial is an early stage of research where a new treatment is given to a larger group of people to see if it works, measure its safety, and find the best dose.
Why can't I see all the details of this study?
The Health Research Authority (HRA) has allowed the researchers to delay sharing the full details to protect new discoveries. All information will be public within 30 months after the trial finishes.
Who can join this study?
This study is looking for men and women aged between 40 and 85 years old. Further specific details are not available yet.
Will my privacy be protected if I join?
Yes, all clinical trials must follow strict rules to protect your personal information and privacy throughout the study.
Can I leave the study if I change my mind?
Yes, you are always free to withdraw from any clinical trial at any point, without having to give a reason, and without it affecting your routine medical care.
How to find out more
Christopher Brightling
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.